# Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer

> **NCT03264807** · PHASE3 · UNKNOWN · sponsor: **National Cancer Center, Korea** · enrollment: 518 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **PROCEDURE:** D2 lymphadenectomy
- **PROCEDURE:** D2 and #14v lymphadenectomy

## Key facts

- **NCT ID:** NCT03264807
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08-06
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 518 (ESTIMATED)
- **Last updated:** 2020-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03264807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03264807, "Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03264807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*